FDA Watch: FDA Approves Enhanced Cologuard Cancer Test
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
The relief package agreed to on April 4 appears to have become a collateral victim of a politically incendiary issue regarding immigration.
amesh “Sunny” Balwani’s legal team makes the case that Holmes is solely responsible for Theranos misdoings.
Legislation would require Medicare to cover genomic cancer testing and follow-up screening for those with a family history of cancer.
The ONC requested input on certification standards for the development and implementation of electronic prior authorization IT products.
A new case from the US Court of Appeals for the Ninth Circuit tests how far the public disclosure bar goes.